UNSPSC 51284706: Retapamulin

This classification denotes an antibiotic, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 4MG6O8991R. European Medicines Agency schedules Retapamulin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB25391. Retapamulin generally arises in the molecular formula C30H47NO4S. The term RETAPAMULIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 19, no. 1, 2005, list 53.) Most nations schedule retapamulin under HS 29419000 and SITC 54139.

As of Q4 2014, RETAPAMULIN remains the US FDA Preferred Term for this commodity. Retapamulin bears US NLM identifiers UMLS ID C1703334 and NCI Concept Code C61924. SMILES: S(C1CC2N(C(C1)CC2)C)CC(=O)OC1C2(C3C(C(C(O)C(C1)(C)C=C)C)(CCC2C)CCC3=O)C.

UNSPSC 51284706 Retapamulin is a Commodity code nominally covering a specific topical antibiotic product, but the recent state and local opportunities tagged to this code show minimal alignment with retapamulin procurement itself. Instead, the code's recent activity spans a broader mix of pharmaceutical, medical supply, and pharmacy program solicitations — from naloxone and drug deactivation systems to generic multi-source pharmaceuticals distributed through state cooperative purchasing. State and local issuing bodies soliciting under this code include county health departments (Seminole County, Florida), state HHS commissions (Texas Health and Human Services Commission), municipal fire departments (City of Tampa Fire Department), and multi-state cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance, serving state and local facilities across participating jurisdictions including Oregon). The work being solicited ranges from direct pharmaceutical product procurement — naloxone and emergency medical supplies for immediate community health response — to broader pharmacy benefit program design and generic drug sourcing through established wholesaler networks.

Recent opportunities span Florida, Texas, Minnesota, and Oregon. Seminole County, Florida issued IFB 60459723LAS on June 30, 2026 (due July 26, 2023) to procure 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford; the contract carries a two-year initial term with one-year renewal option and is potentially FEMA-funded. The City of Tampa issued ITB 26P00145 on March 25, 2026 (due March 13, 2026) for 169 line items of medical and first aid supplies for the Tampa Fire Department Rescue Division with an estimated contract value of $700,000, designated as a sheltered market opportunity exclusively for certified Small Local Business Enterprises with a 5 percent bid discount. The Texas Health and Human Services Commission posted RFI HHS0017013 on April 3, 2026 to gather vendor capabilities regarding direct-to-manufacturer prescription programs. The Minnesota Multistate Cooperative Purchasing Alliance issued RFP S1070000015802 on January 20, 2026 (due March 26, 2026) for generic multi-source pharmaceuticals and OTC products, with awarded vendors to take effect July 1, 2026 and supply through three authorized wholesalers.